# ONL Therapeutics funding: rounds and investors > ONL Therapeutics has raised $67M across 3 rounds since 2014. Investors include National Institutes of Health and Novartis. Every round with its source. Source: https://millionrounds.com/company/onl-therapeutics (Millionrounds; every figure on the page links to its filing or article) United States · [Series D startup](https://millionrounds.com/companies) # Who invested in *ONL Therapeutics* 3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Funding summary Updated 26 Oct 2026 **$67M** raised across 3 rounds since 2014, from 3 sources **$502K** Seed **$1.4M** Grant **$65M** Series D - **Latest round:** Series D, $65M Sept 2024 - **Step-up i:** 47.4× - **Investors:** 2 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2014 2016 2018 2020 2022 2024 **$502K** Seed **$1.4M** Grant **$65M** Series D - **First round:** Seed, $502K - **Biggest round:** $65M - **Usual gap between rounds:** 9.8 years ## The rounds - **Sept 2024** Series D **$65M** *2 new* [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) [Novartis](https://millionrounds.com/fund/novartis) Source recorded SEC filing: $60M sold, first sale Sept 2024 - **Nov 2014** Grant **$1.4M** No investor was named in the report. From a historical funding record - **Jul 2014** Seed **$502K** No investor was named in the report. From a historical funding record SEC filing: $502K sold, first sale Jun 2014 ## Founders and team From ONL Therapeutics's own website: 7 on the team. - **David Esposito** President and Chief Executive Officer - **Amanda Maciel** Director of Finance - **Anjalie Mahabir** Project Manager, Clinical Operations - **Kristin Hanley** Lead Regulatory and Compliance Consultant - **Linda Kemnitz** Manager, Administrative Operations - **Nicole Rose** Director, Clinical Operations - **Rackham Graduate School** 2023 intern ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Seed** 2014 **Grant** 2014 **Series D** 2024 [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) [Novartis](https://millionrounds.com/fund/novartis) ## Everyone who backed them [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) Government **1** round [Novartis](https://millionrounds.com/fund/novartis) VC firm **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=onl-therapeutics). ## Also claim to have backed them These 4 firms list ONL Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above. [ExSight Ventures](https://millionrounds.com/fund/exsight-ventures) VC firm Series B, per its site [Visionary Ventures Fund](https://millionrounds.com/fund/visionary-ventures-fund) VC firm Per its own site [Invest Michigan](https://millionrounds.com/fund/invest-michigan) VC firm Per its own site [Accelerate Blue Fund](https://millionrounds.com/fund/accelerate-blue-fund) VC firm Per its own site ## Quick answers about ONL Therapeutics ### Who invested in ONL Therapeutics? ONL Therapeutics's investors include National Institutes of Health and Novartis. ### How much has ONL Therapeutics raised? ONL Therapeutics has raised $67M across 3 rounds since 2014. ### When did ONL Therapeutics last raise? ONL Therapeutics's most recent round was a Series D of $65M in Sept 2024. ### What was ONL Therapeutics's biggest round? Its most recent round, $65M in Sept 2024, is also its largest on record. ### Who backed ONL Therapeutics first? ONL Therapeutics's first round on record, in Sept 2024, was backed by National Institutes of Health and Novartis. ### What stage is ONL Therapeutics at? ONL Therapeutics's latest named round is a Series D, in Sept 2024. ### Where is ONL Therapeutics based? ONL Therapeutics is based in the United States. ## Companies like ONL Therapeutics In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app